Summit Trail Advisors LLC Sells 876 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Summit Trail Advisors LLC decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 21.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,128 shares of the company’s stock after selling 876 shares during the period. Summit Trail Advisors LLC’s holdings in HealthEquity were worth $300,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Raymond James Trust N.A. boosted its stake in shares of HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after buying an additional 132 shares during the period. UMB Bank n.a. raised its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares in the last quarter. Truist Financial Corp lifted its position in shares of HealthEquity by 7.0% during the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after acquiring an additional 188 shares during the period. Nicolet Advisory Services LLC grew its holdings in shares of HealthEquity by 5.8% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock worth $330,000 after purchasing an additional 233 shares in the last quarter. Finally, Exchange Traded Concepts LLC increased its position in shares of HealthEquity by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 9,813 shares of the company’s stock worth $942,000 after purchasing an additional 245 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Price Performance

HealthEquity stock opened at $114.51 on Thursday. The stock has a 50-day moving average price of $101.63 and a two-hundred day moving average price of $90.37. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $114.69. The company has a market capitalization of $9.92 billion, a PE ratio of 105.06, a P/E/G ratio of 1.61 and a beta of 0.55. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the business posted $0.40 earnings per share. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on HQY. JMP Securities upped their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Royal Bank of Canada upped their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Bank of America lifted their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Barrington Research upped their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Finally, Mizuho assumed coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Transactions at HealthEquity

In other news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,000 shares of company stock worth $3,895,788. Company insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.